Avanos MedicalAVNS -0.04%62 14-Day RSI is 59.23 as of Jul. 13, 2026. GuruFocus rates AVNS with a GF Score™ of 62/100 and a GF Value™ of $19.39 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 868 Medical Devices & Instruments companies, Avanos Medical ranks worse than 83.87% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-13), Avanos Medical's 14-Day RSI is 59.23.
The industry rank for Avanos Medical's 14-Day RSI or its related term are showing as below:
AVNS's 14-Day RSI is ranked worse than 83.87% of 868
companies
in the Medical Devices & Instruments industry
Industry Median: 47.695
vs AVNS: 59.23
Avanos Medical (NYSE:AVNS) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Avanos Medical 14-Day RSI Related Terms
AVNS vs LMRI, AORT, IRMD: 14-Day RSI Comparison
For the Medical Devices subindustry, Avanos Medical's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avanos Medical 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avanos Medical's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Avanos Medical's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avanos Medical (AVNS) has a 14-Day RSI of 59.23 as of Jul. 13, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Avanos Medical and its competitors. According to the industry distribution chart, Avanos Medical ranks #728 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 83.9%.
Is Avanos Medical's 14-Day RSI too high?
Avanos Medical's current 14-Day RSI is 59.23. The Medical Devices & Instruments industry median 14-Day RSI is 47.70. Avanos Medical's value of 59.23 is 24.2% above this industry median. Based on the distribution chart, Avanos Medical ranks #728 out of 868 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Avanos Medical has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Avanos Medical's 14-Day RSI compare to LMRI and AORT?
According to the Medical Devices & Instruments industry distribution chart, Avanos Medical ranks #728 out of 868 companies for 14-Day RSI. This places Avanos Medical in the lower half of its industry. The industry median 14-Day RSI is 47.70. Avanos Medical's value of 59.23 is 24.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 47.70, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avanos Medical's current 14-Day RSI of 59.23 is 24.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Avanos Medical and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 47.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avanos Medical's current 14-Day RSI is 59.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avanos Medical stock overvalued right now?
Based on GuruFocus' analysis, Avanos Medical (AVNS) is currently considered Modestly Overvalued. The stock's GF Value™ is $19.39, compared to a current price of $24.93 — trading 28.6% above its estimated fair value. The current 14-Day RSI is 59.23 and 24.2% above the Medical Devices & Instruments industry median of 47.70. Avanos Medical's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Avanos Medical (AVNS), the current 14-Day RSI is 59.23 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avanos Medical (AVNS) Overvalued in 2026?
Based on GuruFocus' analysis, Avanos Medical stock appears to be overvalued.
The current stock price of $24.93 is trading 28.6% above its estimated GF Value™ of $19.39.
GuruFocus considers Avanos Medical to be Modestly Overvalued.
Key valuation signals for AVNS:
14-Day RSI: 59.23
GF Value™: $19.39 vs. price of $24.93 (28.6% above fair value)
Industry Position: 24.2% above the Medical Devices & Instruments median (#728 of 868)
No single metric tells the full story. See the AVNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
62GF Score
Get the complete analysis for AVNS
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVNS has been successfully added to your 